04.02.2020
The Haavind Pharma Report Winter 2020
In the Pharma Report Winter 2020, we take a retrospective look at some of the legal developments during the second half of 2019 in the Norwegian pharmaceutical sector.
News
-
-
06.01.2020Asset management – proposal for fees for cross-border marketing
FSAN has recently proposed to introduce fees for some managers. It is likely that implementation, if proposal is adopted by the MoF, will be as soon as practically possible.
-
02.01.2020Who’s Who Legal names Mikal Brøndmo a Future Leader of Arbitration
We are proud to announce that Who’s Who Legal recognizes Partner Mikal Brøndmo as a Future Leader of Arbitration in its 2020 Global List.
-
19.12.2019Haavind strengthens its position in important areas
We are proud to present three new partners, in competition law, dispute resolution / public procurement and banking and finance.
Corporate M&A
Norwegian M&A at a glance – 2018 in review
Haavind’s annual update on Norwegian M&A and Capital Markets